Amyris, Inc. (AMRS)
(Delayed Data from NSDQ)
$5.04 USD
+0.60 (13.51%)
Updated May 3, 2019 04:00 PM ET
After-Market: $5.05 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[AMRS]
Reports for Purchase
Showing records 1 - 20 ( 147 total )
Industry: Chemical - Specialty
Industry: Chemical - Specialty
Financial Restructuring Underway; Placing Under Review
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAYAL A
Industry: Chemical - Specialty
Industry: Chemical - Specialty
Difficult 1Q23; Cash Burn and Non- Dilutive Financing Are a Focus
Provider: Roth Capital Partners, Inc.
Analyst: IRWIN C
Industry: Chemical - Specialty
Focus on Improving Cost Structure and Liquidity; 1Q23 Results Update
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAYAL A
Industry: Chemical - Specialty
Industry: Chemical - Specialty
Industry: Chemical - Specialty
Industry: Chemical - Specialty
Lowering PT to $5.00 to Reflect Adjustments to Estimates; 4Q22 Results Update
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAYAL A
Industry: Chemical - Specialty
Industry: Chemical - Specialty
Weak 3Q22; Balance Sheet Challenges Again As Cash Burn Remains Too High
Provider: Roth Capital Partners, Inc.
Analyst: IRWIN C
Industry: Chemical - Specialty
Industry: Chemical - Specialty
Industry: Chemical - Specialty
Industry: Chemical - Specialty
Industry: Chemical - Specialty
Own Manufacturing Facility Should Help Improve Margins by Year-End; Maintain Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAYAL A
Industry: Chemical - Specialty
Industry: Chemical - Specialty
1Q22 Miss; Aggressive Spending to Maintain Green Chemistry Leadership
Provider: Roth Capital Partners, Inc.
Analyst: IRWIN C
Industry: Chemical - Specialty
Brands Continue to Drive Revenue Growth; Lowering Price Target to $22 on Near-Term Margin Adjustments; Maintain Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAYAL A